Reshma Rangwala
Chief Tech/Sci/R&D Officer at KARYOPHARM THERAPEUTICS INC.
Net worth: 517 826 $ as of 30/03/2024
Profile
Reshma Rangwala is currently the Chief Medical Officer & Executive Vice President at Karyopharm Therapeutics, Inc. Prior to this, she held positions as the Executive Clinical Director at Merck & Co., Inc. from 2012 to 2017, Vice President-Medical at Genmab, Inc. from 2017 to 2020, and Chief Medical Officer at Aravive, Inc. from 2020 to 2022.
Dr. Rangwala completed her undergraduate degree at Duke University and obtained her doctorate from The University of Cincinnati College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/04/2024 | 342,931 ( 0.30% ) | 517 826 $ | 30/03/2024 |
Reshma Rangwala active positions
| Companies | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 31/03/2022 |
Former positions of Reshma Rangwala
| Companies | Position | End |
|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 27/03/2022 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 30/06/2020 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 30/04/2017 |
Training of Reshma Rangwala
| Duke University | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |
- Stock Market
- Insiders
- Reshma Rangwala
